Study: Anti-smoking drug raises risk of heart attack

July 8, 2011 (WASHINGTON)

The findings of the new study recently published in the Canadian Medical Association Journal have prompted the U.S. Food and Drug Administration to issue a statement that advising that "the known benefits of Chantix should be weighed against its potential risks when deciding to use the drug in smokers with cardiovascular disease."

The conclusions of the new research come a little more than one week after the FDA reported that the use of Chantix among people with heart disease poses a small yet significant risk of heart attack and stroke based on the results of a study of 700 people.

Copyright © 2021 WLS-TV. All Rights Reserved.